FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088833308> ?p ?o ?g. }

• W2088833308 endingPage "2087.e6" @default.
• W2088833308 startingPage "2076" @default.
• W2088833308 abstract "Background & AimsHuman epidermal growth factor receptor 2 (HER2) (neu/ERBB2) is overexpressed on many types of cancer cells, including gastric cancer cells; HER2 overexpression has been associated with metastasis and poor prognosis. We investigated the mechanisms by which HER2 regulates cell migration and invasion.MethodsHER2 expression or activity was reduced in gastric cancer cell lines using small interfering RNAs or the monoclonal antibody, trastuzumab. We identified proteins that interact with HER2 or microRNAs (miRNAs) involved in HER2 signaling. We used various software programs to identify miRNAs that regulate factors in the HER2 signaling pathway. We analyzed expression patterns of these miRNAs in gastric cancer cell lines and tumor samples from patients.ResultsWe found that CD44 binds directly to HER2, which up-regulates the expression of metastasis-associated protein-1, induces deacetylation of histone H3 lysine 9, and suppresses transcription of microRNA139 (miR-139) to inhibit expression of its target gene, C-X-C chemokine receptor type 4 (CXCR4). Knockdown of HER2 and CD44 reduced invasive activity of cultured gastric cancer cells and suppressed tumor growth in nude mice. Lymph node metastasis was associated with high levels of HER2, CD44, and CXCR4, and reduced levels of miR-139 in human metastatic gastric tumors. Cultures of different types of metastatic cancer cells with histone deacetylase inhibitors and/or DNA methyltransferase resulted in up-regulation of miR-139.ConclusionsHER2 interaction with CD44 up-regulates CXCR4 by inhibiting expression of miR-139, at the epigenetic level, in gastric cancer cells. These findings indicate how HER2 signaling might promote gastric tumor progression and metastasis. Human epidermal growth factor receptor 2 (HER2) (neu/ERBB2) is overexpressed on many types of cancer cells, including gastric cancer cells; HER2 overexpression has been associated with metastasis and poor prognosis. We investigated the mechanisms by which HER2 regulates cell migration and invasion. HER2 expression or activity was reduced in gastric cancer cell lines using small interfering RNAs or the monoclonal antibody, trastuzumab. We identified proteins that interact with HER2 or microRNAs (miRNAs) involved in HER2 signaling. We used various software programs to identify miRNAs that regulate factors in the HER2 signaling pathway. We analyzed expression patterns of these miRNAs in gastric cancer cell lines and tumor samples from patients. We found that CD44 binds directly to HER2, which up-regulates the expression of metastasis-associated protein-1, induces deacetylation of histone H3 lysine 9, and suppresses transcription of microRNA139 (miR-139) to inhibit expression of its target gene, C-X-C chemokine receptor type 4 (CXCR4). Knockdown of HER2 and CD44 reduced invasive activity of cultured gastric cancer cells and suppressed tumor growth in nude mice. Lymph node metastasis was associated with high levels of HER2, CD44, and CXCR4, and reduced levels of miR-139 in human metastatic gastric tumors. Cultures of different types of metastatic cancer cells with histone deacetylase inhibitors and/or DNA methyltransferase resulted in up-regulation of miR-139. HER2 interaction with CD44 up-regulates CXCR4 by inhibiting expression of miR-139, at the epigenetic level, in gastric cancer cells. These findings indicate how HER2 signaling might promote gastric tumor progression and metastasis." @default.
• W2088833308 created "2016-06-24" @default.
• W2088833308 creator A5005368955 @default.
• W2088833308 creator A5006088751 @default.
• W2088833308 creator A5012791993 @default.
• W2088833308 creator A5023708789 @default.
• W2088833308 creator A5031464945 @default.
• W2088833308 creator A5041466379 @default.
• W2088833308 creator A5048430972 @default.
• W2088833308 creator A5053780153 @default.
• W2088833308 creator A5056755738 @default.
• W2088833308 creator A5065037360 @default.
• W2088833308 creator A5066835185 @default.
• W2088833308 creator A5069582554 @default.
• W2088833308 creator A5073216396 @default.
• W2088833308 creator A5084260677 @default.
• W2088833308 creator A5084357635 @default.
• W2088833308 creator A5085142676 @default.
• W2088833308 creator A5088323967 @default.
• W2088833308 creator A5091267271 @default.
• W2088833308 date "2011-12-01" @default.
• W2088833308 modified "2023-10-18" @default.
• W2088833308 title "HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells" @default.
• W2088833308 cites W1969499061 @default.
• W2088833308 cites W1975377745 @default.
• W2088833308 cites W1983798380 @default.
• W2088833308 cites W1988863549 @default.
• W2088833308 cites W1992185689 @default.
• W2088833308 cites W1993804787 @default.
• W2088833308 cites W2006174096 @default.
• W2088833308 cites W2006508449 @default.
• W2088833308 cites W2009802552 @default.
• W2088833308 cites W2017397076 @default.
• W2088833308 cites W2018939316 @default.
• W2088833308 cites W2030166934 @default.
• W2088833308 cites W2037632318 @default.
• W2088833308 cites W2038325417 @default.
• W2088833308 cites W2046108122 @default.
• W2088833308 cites W2070994956 @default.
• W2088833308 cites W2078669402 @default.
• W2088833308 cites W2083605403 @default.
• W2088833308 cites W2089071484 @default.
• W2088833308 cites W2092868756 @default.
• W2088833308 cites W2093295719 @default.
• W2088833308 cites W2100439220 @default.
• W2088833308 cites W2101037339 @default.
• W2088833308 cites W2102650381 @default.
• W2088833308 cites W2118017318 @default.
• W2088833308 cites W2121382969 @default.
• W2088833308 cites W2126336008 @default.
• W2088833308 cites W2126894693 @default.
• W2088833308 cites W2129004989 @default.
• W2088833308 cites W2133105825 @default.
• W2088833308 cites W2136021600 @default.
• W2088833308 cites W2144038313 @default.
• W2088833308 cites W2145021085 @default.
• W2088833308 cites W2156323704 @default.
• W2088833308 cites W2159141617 @default.
• W2088833308 cites W2162841642 @default.
• W2088833308 cites W4294352168 @default.
• W2088833308 doi "https://doi.org/10.1053/j.gastro.2011.08.050" @default.
• W2088833308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21925125" @default.
• W2088833308 hasPublicationYear "2011" @default.
• W2088833308 type Work @default.
• W2088833308 sameAs 2088833308 @default.
• W2088833308 citedByCount "133" @default.
• W2088833308 countsByYear W20888333082012 @default.
• W2088833308 countsByYear W20888333082013 @default.
• W2088833308 countsByYear W20888333082014 @default.
• W2088833308 countsByYear W20888333082015 @default.
• W2088833308 countsByYear W20888333082016 @default.
• W2088833308 countsByYear W20888333082017 @default.
• W2088833308 countsByYear W20888333082018 @default.
• W2088833308 countsByYear W20888333082019 @default.
• W2088833308 countsByYear W20888333082020 @default.
• W2088833308 countsByYear W20888333082021 @default.
• W2088833308 countsByYear W20888333082022 @default.
• W2088833308 countsByYear W20888333082023 @default.
• W2088833308 crossrefType "journal-article" @default.
• W2088833308 hasAuthorship W2088833308A5005368955 @default.
• W2088833308 hasAuthorship W2088833308A5006088751 @default.
• W2088833308 hasAuthorship W2088833308A5012791993 @default.
• W2088833308 hasAuthorship W2088833308A5023708789 @default.
• W2088833308 hasAuthorship W2088833308A5031464945 @default.
• W2088833308 hasAuthorship W2088833308A5041466379 @default.
• W2088833308 hasAuthorship W2088833308A5048430972 @default.
• W2088833308 hasAuthorship W2088833308A5053780153 @default.
• W2088833308 hasAuthorship W2088833308A5056755738 @default.
• W2088833308 hasAuthorship W2088833308A5065037360 @default.
• W2088833308 hasAuthorship W2088833308A5066835185 @default.
• W2088833308 hasAuthorship W2088833308A5069582554 @default.
• W2088833308 hasAuthorship W2088833308A5073216396 @default.
• W2088833308 hasAuthorship W2088833308A5084260677 @default.
• W2088833308 hasAuthorship W2088833308A5084357635 @default.
• W2088833308 hasAuthorship W2088833308A5085142676 @default.
• W2088833308 hasAuthorship W2088833308A5088323967 @default.
• W2088833308 hasAuthorship W2088833308A5091267271 @default.
• W2088833308 hasBestOaLocation W20888333081 @default.

• next